# JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

> **NCT01830829** · PHASE3 · TERMINATED · sponsor: **Dr. J. Curtis Nickel** · enrollment: 1 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia
- Chronic Prostatitis

## Interventions

- **DRUG:** Jalyn
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01830829
- **Lead sponsor:** Dr. J. Curtis Nickel
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Difficulty in enrolling particpants
- **Last updated:** 2014-10-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01830829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01830829, "JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01830829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*